Phase of Development: Lead Optimization

Mechanism of Action: Tau Phosphorylation and Posttranslational Modifications

Compound Type/Modality: Antibody/Biologic

Developing Biomarkers and Vectorized Immunotherapy Targeting Acetylated Tau

Li Gan, PhD

Director, Helen and Robert Appel Alzheimer's Disease Research Institute
Cornell Weill Medical Institute (New York, NY)